Loading…

Immunologic indices in myelodysplastic syndromes

Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A....

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1988-03, Vol.61 (6), p.1075-1081
Main Authors: Colombat, Philippe H., Renoux, Micheline, Lamagnere, Jean‐Pierre, Renoux, Gerory
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1081
container_issue 6
container_start_page 1075
container_title Cancer
container_volume 61
creator Colombat, Philippe H.
Renoux, Micheline
Lamagnere, Jean‐Pierre
Renoux, Gerory
description Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.
doi_str_mv 10.1002/1097-0142(19880315)61:6<1075::AID-CNCR2820610604>3.0.CO;2-E
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_78116587</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78116587</sourcerecordid><originalsourceid>FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303</originalsourceid><addsrcrecordid>eNpdkN1Kw0AQRhdRaq0-gtAr0YvUmf1NqgglVi0UC6Lg3ZBuNhJJmpptkby9Ka0FvfoYzjcDcxiLEQYIwK8RIhMASn6JURiCQHWlcahvEYwaDkeT-yB-jl94yEEjaJB3YgCDeHbDg_EB6-63D1kXAMJASfF-zE68_2xHw5XosI7gyhiIugwmZbleVEX1kdt-vkhz63yb_bJxRZU2flkkftUi3yzSuiqdP2VHWVJ4d7bLHnt7GL_GT8F09jiJR9NgiTKUgRXCcWsNzKPQSJVhZLXSaZIoiwoTMFZrnIPUmdFCcylTbbJ5woWWmXMCRI9dbO8u6-pr7fyKytxbVxTJwlVrTyZE1Co0bfF8V1zPS5fSss7LpG5o92LLsy3_zgvX7DECbWTTRhdtdNGvbNJImjayqXVNf12TIKB4RpzG_4j4AZq1d7g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78116587</pqid></control><display><type>article</type><title>Immunologic indices in myelodysplastic syndromes</title><source>EZB Electronic Journals Library</source><creator>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</creator><creatorcontrib>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</creatorcontrib><description>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/1097-0142(19880315)61:6&lt;1075::AID-CNCR2820610604&gt;3.0.CO;2-E</identifier><identifier>PMID: 3257709</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Anemia, Refractory, with Excess of Blasts - immunology ; Anemia, Sideroblastic - immunology ; Female ; Humans ; Immunoglobulin A - analysis ; Immunoglobulin G - analysis ; Immunoglobulin M - analysis ; Leukemia, Myeloid - immunology ; Leukocyte Count ; Lymphocyte Activation - drug effects ; Male ; Middle Aged ; Myelodysplastic Syndromes - immunology ; Prognosis ; Receptors, Antigen, B-Cell - analysis ; T-Lymphocytes - classification ; T-Lymphocytes - immunology</subject><ispartof>Cancer, 1988-03, Vol.61 (6), p.1075-1081</ispartof><rights>Copyright © 1988 American Cancer Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/3257709$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Colombat, Philippe H.</creatorcontrib><creatorcontrib>Renoux, Micheline</creatorcontrib><creatorcontrib>Lamagnere, Jean‐Pierre</creatorcontrib><creatorcontrib>Renoux, Gerory</creatorcontrib><title>Immunologic indices in myelodysplastic syndromes</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Anemia, Refractory, with Excess of Blasts - immunology</subject><subject>Anemia, Sideroblastic - immunology</subject><subject>Female</subject><subject>Humans</subject><subject>Immunoglobulin A - analysis</subject><subject>Immunoglobulin G - analysis</subject><subject>Immunoglobulin M - analysis</subject><subject>Leukemia, Myeloid - immunology</subject><subject>Leukocyte Count</subject><subject>Lymphocyte Activation - drug effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myelodysplastic Syndromes - immunology</subject><subject>Prognosis</subject><subject>Receptors, Antigen, B-Cell - analysis</subject><subject>T-Lymphocytes - classification</subject><subject>T-Lymphocytes - immunology</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1988</creationdate><recordtype>article</recordtype><recordid>eNpdkN1Kw0AQRhdRaq0-gtAr0YvUmf1NqgglVi0UC6Lg3ZBuNhJJmpptkby9Ka0FvfoYzjcDcxiLEQYIwK8RIhMASn6JURiCQHWlcahvEYwaDkeT-yB-jl94yEEjaJB3YgCDeHbDg_EB6-63D1kXAMJASfF-zE68_2xHw5XosI7gyhiIugwmZbleVEX1kdt-vkhz63yb_bJxRZU2flkkftUi3yzSuiqdP2VHWVJ4d7bLHnt7GL_GT8F09jiJR9NgiTKUgRXCcWsNzKPQSJVhZLXSaZIoiwoTMFZrnIPUmdFCcylTbbJ5woWWmXMCRI9dbO8u6-pr7fyKytxbVxTJwlVrTyZE1Co0bfF8V1zPS5fSss7LpG5o92LLsy3_zgvX7DECbWTTRhdtdNGvbNJImjayqXVNf12TIKB4RpzG_4j4AZq1d7g</recordid><startdate>19880315</startdate><enddate>19880315</enddate><creator>Colombat, Philippe H.</creator><creator>Renoux, Micheline</creator><creator>Lamagnere, Jean‐Pierre</creator><creator>Renoux, Gerory</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>19880315</creationdate><title>Immunologic indices in myelodysplastic syndromes</title><author>Colombat, Philippe H. ; Renoux, Micheline ; Lamagnere, Jean‐Pierre ; Renoux, Gerory</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1988</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Anemia, Refractory, with Excess of Blasts - immunology</topic><topic>Anemia, Sideroblastic - immunology</topic><topic>Female</topic><topic>Humans</topic><topic>Immunoglobulin A - analysis</topic><topic>Immunoglobulin G - analysis</topic><topic>Immunoglobulin M - analysis</topic><topic>Leukemia, Myeloid - immunology</topic><topic>Leukocyte Count</topic><topic>Lymphocyte Activation - drug effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myelodysplastic Syndromes - immunology</topic><topic>Prognosis</topic><topic>Receptors, Antigen, B-Cell - analysis</topic><topic>T-Lymphocytes - classification</topic><topic>T-Lymphocytes - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Colombat, Philippe H.</creatorcontrib><creatorcontrib>Renoux, Micheline</creatorcontrib><creatorcontrib>Lamagnere, Jean‐Pierre</creatorcontrib><creatorcontrib>Renoux, Gerory</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Colombat, Philippe H.</au><au>Renoux, Micheline</au><au>Lamagnere, Jean‐Pierre</au><au>Renoux, Gerory</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Immunologic indices in myelodysplastic syndromes</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>1988-03-15</date><risdate>1988</risdate><volume>61</volume><issue>6</issue><spage>1075</spage><epage>1081</epage><pages>1075-1081</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Immunocompetence was evaluated in 36 untreated and noninfected patients affected with myelodysplastic syndromes (MDS). T‐cell number and activity were evaluated by counts of total T‐cells and T‐lymphocyte subsets, and by measure of DNA synthesis in response to phytohemagglutinin and Concanavalin A. B‐cells were evaluated as surface immunoglobulin‐ (SIg+) bearing cells and by serum immuno‐globulin levels. Granulocyte activities were evaluated by responses to chemotaxis and to nitroblue tetrazolium test. Complement activity was measured by classic hemolytic complement assay. In addition, circulating immune complexes were detected in serum. MDS were associated with a significant decrease in the absolute numbers of total T (E‐rosetting and T3+) cells, T4+, and T8+ cells and a dramatic decrease of the responses to Concanavalin A. An impairment of either chemotaxis or of nitroblue tetrazolium (NBT) test was frequently encountered. An increase in the levels of IgG or IgA was also a frequent feature. The findings reveal that all patients with a high degree of T‐cell impairment have refractory anemia associated with an excess of medullary blast cells. All in all, the data suggest that the counts of the absolute number of cells bearing the T3 and T8 phenotypes could be of prognostic value: the higher the number, the better the patient's survival.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>3257709</pmid><doi>10.1002/1097-0142(19880315)61:6&lt;1075::AID-CNCR2820610604&gt;3.0.CO;2-E</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-543X
ispartof Cancer, 1988-03, Vol.61 (6), p.1075-1081
issn 0008-543X
1097-0142
language eng
recordid cdi_proquest_miscellaneous_78116587
source EZB Electronic Journals Library
subjects Adult
Aged
Aged, 80 and over
Anemia, Refractory, with Excess of Blasts - immunology
Anemia, Sideroblastic - immunology
Female
Humans
Immunoglobulin A - analysis
Immunoglobulin G - analysis
Immunoglobulin M - analysis
Leukemia, Myeloid - immunology
Leukocyte Count
Lymphocyte Activation - drug effects
Male
Middle Aged
Myelodysplastic Syndromes - immunology
Prognosis
Receptors, Antigen, B-Cell - analysis
T-Lymphocytes - classification
T-Lymphocytes - immunology
title Immunologic indices in myelodysplastic syndromes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T07%3A04%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Immunologic%20indices%20in%20myelodysplastic%20syndromes&rft.jtitle=Cancer&rft.au=Colombat,%20Philippe%20H.&rft.date=1988-03-15&rft.volume=61&rft.issue=6&rft.spage=1075&rft.epage=1081&rft.pages=1075-1081&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/1097-0142(19880315)61:6%3C1075::AID-CNCR2820610604%3E3.0.CO;2-E&rft_dat=%3Cproquest_pubme%3E78116587%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p1484-c33e2cc70b98745f19c656daa5c151a07c661b046f7636244d67fba2364fee303%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78116587&rft_id=info:pmid/3257709&rfr_iscdi=true